← Leaderboards
Jagdish Singh
North Dakota State University
$4,468,047
Attributed
$7,716,602
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,716,602 · 11
By mechanism
R01$4,868,560 · 3
RF1$1,628,551 · 1
R03$707,338 · 5
R15$348,000 · 1
P20$164,153 · 1
Top collaborators
- Takahisa Kanekiyo13 shared
Most similar at North Dakota State University
Same institution · by research overlap
- Takahisa Kanekiyo$19,312,429
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposIn VivoIn VitroBiomaterial CompatibilityPreventionNon-Viral Gene DeliveryNanoparticleS DiseaseGene TherapySurfaceAmericanVectorCellsGene DeliveryZeta PotentialMediatingToxic EffectTransfectionProteinsChitosanNeurodegenerative DisordersMicellesBrainNeurons
Grant awards (25)
Therapeutic Strategy to Treat Alzheimer's Disease by VGF Delivery into Brain$606,012
R01 · FY2025 · AG · contact PI
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease$515,197
R01 · FY2025 · AG · contact PI
Therapeutic Strategy to Treat Alzheimer's Disease by VGF Delivery into Brain$580,803
R01 · FY2024 · AG · contact PI
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease$525,712
R01 · FY2024 · AG · contact PI
Therapeutic Strategy to Treat Alzheimer's Disease by VGF Delivery into Brain$600,211
R01 · FY2023 · AG · contact PI
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease$190,981
RF1 · FY2022 · AG · contact PI
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease$1,437,570
RF1 · FY2021 · AG · contact PI
Brain Neurotropic Growth Factor Delivery to Prevent and Treat Alzheimer's Disease$376,875
R01 · FY2020 · AG · contact PI
Brain Neurotropic Growth Factor Delivery to Prevent and Treat Alzheimerâs Disease$376,875
R01 · FY2019 · AG · contact PI
Brain Neurotropic Growth Factor Delivery to Prevent and Treat Alzheimerâs Disease$376,875
R01 · FY2018 · AG · contact PI
Apoe based solid nanoparticles for prevention and treatment of Alzheimer's Disease$145,000
R01 · FY2018 · AG · contact PI
Brain Neurotropic Growth Factor Delivery to Prevent and Treat Alzheimerâs Disease$376,875
R01 · FY2017 · AG · contact PI
Brain Neurotropic Growth Factor Delivery to Prevent and Treat Alzheimerâs Disease$388,125
R01 · FY2016 · AG · contact PI
Modification of insulin molecule for controlled delivery at basal level from triblock copolymers$348,000
R15 · FY2015 · GM · contact PI
Controlled delivery of polypeptide hormone calcitonin$68,513
R03 · FY2013 · AG · contact PI
Controlled delivery of polypeptide hormone calcitonin$72,250
R03 · FY2012 · AG · contact PI
Prevention of diabetes by pDNA encoded with IL-10$71,750
R03 · FY2010 · HD · contact PI
Prevention of diabetes by pDNA encoded with IL-10$71,750
R03 · FY2009 · HD · contact PI
Controlled Delivery of Insulin$69,825
R03 · FY2008 · HD · contact PI
Controlled Delivery of Insulin$71,250
R03 · FY2007 · HD · contact PI
Novel Controlled Delivery Systems for Contraceptives$70,500
R03 · FY2005 · HD
PHARMACEUTICAL SCIENCES START UP$164,153
P20 · FY2004 · RR
Novel Controlled Delivery Systems for Contraceptives$70,500
R03 · FY2004 · HD
Field-induced pores formation during iontophoresis$70,500
R03 · FY2003 · HD
Field-induced pores formation during iontophoresis$70,500
R03 · FY2002 · HD